Not a good buy right now: price is sitting below/around first support with bearish momentum (MACD worsening) and no proprietary buy signal to override the technical weakness.
Options positioning leans defensive (put-heavy open interest), which typically aligns with near-term caution rather than aggressive dip-buying.
Near-term catalyst (earnings on 2026-02-24) adds event risk; with an impatient profile, the current setup is not favorable for a clean entry.
Trend/Momentum: Bearish; MACD histogram is negative (-1.164) and negatively expanding, indicating downside momentum is strengthening.
RSI (6): ~21.6 (oversold territory in practice), which can enable short bounces, but oversold alone is not a buy signal when MACD keeps deteriorating.
Moving averages: Converging, suggesting indecision/transition, but without a clear bullish turn yet.
Key levels: Immediate support S1 ~34.79 (price ~34.64 is slightly below it), next support S2 ~32.51. Pivot resistance is far above at ~38.49; bulls would want to reclaim/hold above that to shift the structure.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment from positioning: Put open interest (398) exceeds call open interest (239) → OI put/call ratio 1.67, a bearish/hedged stance.
Activity: Very low volume (2 calls, 0 puts) despite open interest build; volume signal is weak/low-confidence.
Volatility: 30D IV 80.6 vs historical vol ~62.4 (options relatively expensive vs realized), while IV percentile/rank are low (11/9), implying current IV is low relative to its own past but still elevated vs realized—mixed for directional conviction.
Technical Summary
Sell
5
Buy
8
Positive Catalysts
Upcoming earnings event: Q4 and full-year 2025 results on 2026-02-24 could act as a catalyst if guidance/margins surprise positively.
Oversold condition near support can trigger a reflex bounce if sellers exhaust and price reclaims ~34.8 quickly.
Recent YoY growth in revenue, net income, and EPS (from latest reported quarter) supports a fundamental rebound narrative if margins stabilize.
Net income: $11.77M, +26.83% YoY (bottom-line improved).
EPS: $0.02, +100% YoY (improvement off a low base).
Gross margin: 12.37%, down 11.01% YoY (key concern: growth came with margin compression).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided in the dataset, so there’s no confirmed recent Street upgrade/downgrade trend to lean on.
Wall Street-style pros (based on available fundamentals): improving YoY revenue/net income/EPS.
Wall Street-style cons (based on available fundamentals/price action): declining gross margin and currently bearish technicals into an earnings catalyst.
Wall Street analysts forecast IMOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMOS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast IMOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMOS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
